MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0004624
Neosun Pharmaceuticals Private Limited
Neosun Pharmaceuticals Private Limited - pharma in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2 Lakh
▼ 59% YoY
Net loss · FY 2025
₹1.72 Lakh
Net margin -85.9%
EBITDA · FY 2025
-₹1.08 Lakh
EBITDA margin -54.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹4 Lakh
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Neosun Pharmaceuticals Private Limited
Data last updated:
Neosun Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51900MH2019PTC331767. Its GSTIN is 27AAGCN7183E1Z9 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Swapna Abhijeet Shiradkar Joshi and Pankaj Shashikantrao Nanajkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sr. No – 8 Plot No. 19/B Kamdhenu Ho. Society Pisadevi Road, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2025, the company reported a revenue of ₹2 Lakh, a decline of 59% compared to the previous year. For the same year it recorded a net loss of ₹1.72 Lakh (net margin -85.9%) and EBITDA of -₹1.08 Lakh (EBITDA margin -54.2%). Revenue has declined at a compounded annual rate (CAGR) of 38% over three years and 1% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
Neosun Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0004624).
Company details
CIN U51900MH2019PTC331767
Registration Number 331767
Incorporation Date 17 October 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0004624
Recognitions & Rankings of Neosun Pharmaceuticals
Contact details
Neosun Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSr. No – 8 Plot No. 19/B Kamdhenu Ho. Society Pisadevi Road, Aurangabad, Maharashtra, India – 431001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Neosun Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Neosun Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Neosun Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Neosun Pharmaceuticals Private Limited, buy the company report.
Financials of Neosun Pharmaceuticals Private Limited
FY 2025 filings availableNeosun Pharmaceuticals Private Limited reported revenue of ₹2 Lakh (down 59% YoY) for FY 2025.
Revenue · FY 2025
₹2 Lakh ▼ 59%
Net loss · FY 2025
₹1.72 Lakh margin -85.9%
EBITDA · FY 2025
-₹1.08 Lakh margin -54.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 59%
3 years · compounded
▼ 38%
5 years · compounded
▼ 1%
EBITDA CAGR growth
1 year
▼ 346%
3 years · compounded
▼ 30%
5 years · compounded
▼ 45%
Revenue has declined at a compounded annual rate (CAGR) of 1% over five years, including a 59% fall in the latest year. EBITDA fell 346% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -54.2% | ||||
| Net Profit Margin | -85.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Neosun Pharmaceuticals Private Limited, buy the company report.
Board of directors of Neosun Pharmaceuticals Private Limited
Neosun Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Swapna Abhijeet Shiradkar Joshi | Director | 17 Oct 2019 | 7 Years 0 Months | Current |
| Pankaj Shashikantrao Nanajkar | Director | 17 Oct 2019 | 7 Years 0 Months | Current |
Auditor
Neosun Pharmaceuticals Private Limited is audited by VIJAY U KSHIRSAGAR & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIJAY U KSHIRSAGAR & ASSOCIATES | FY 2020 | 140061W |
Shareholding
The shareholding of Neosun Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Neosun Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Aug 2022 | 100605335 | Others | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Neosun Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Neosun Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Neosun Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCN7183E1Z9 | Maharashtra | Active | 19 Nov 2019 |
To see the full GST registrations and return filing status of Neosun Pharmaceuticals Private Limited, buy the company report.
Recent activity
Neosun Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Pankaj Shashikantrao Nanajkar was appointed as Director on 17 Oct 2019.
AGM
Neosun Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Neosun Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 5.00 Lakh with Charge ID 100605335 was registered on 03 Aug 2022.
Appointed
Pankaj Shashikantrao Nanajkar was appointed as Director.
Appointed
Swapna Abhijeet Shiradkar Joshi was appointed as Director.
Incorporation
17 Oct 2019
Neosun Pharmaceuticals Private Limited was registered on 17 Oct 2019 with Roc Mumbai Ii & aged 7 years 14 days as per MCA records.
Frequently asked questions
Neosun Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 October 2019 (7+ years old) and is registered under CIN U51900MH2019PTC331767.
Neosun Pharmaceuticals has 2 current directors:
- Swapna Abhijeet Shiradkar Joshi - Director
- Pankaj Shashikantrao Nanajkar - Director
The latest financial statements of Neosun Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Neosun Pharmaceuticals is 27AAGCN7183E1Z9, registered in Maharashtra.
The CIN (Corporate Identification Number) of Neosun Pharmaceuticals is U51900MH2019PTC331767. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Neosun Pharmaceuticals was incorporated on 17 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Pankaj Shashikantrao Nanajkar was appointed as Director on 17 Oct 2019. Swapna Abhijeet Shiradkar Joshi was appointed as Director on 17 Oct 2019.
Yes, Neosun Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0004624).
The registered office of Neosun Pharmaceuticals is at Sr. No – 8 Plot No. 19B Kamdhenu Ho. Society Pisadevi Road, Aurangabad, Maharashtra, India – 431001.
Neosun Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages